Retractable Technologies Q1 net sales $7.2M (down 13% YoY); operating loss widens to $6.2M

RETRACTABLE TECHNOLOGIES INC

2026-Q1 EPS reported -$0.14 revenue$7,177,397

Net sales $7.2M for Q1 2026, down from $8.3M in Q1 2025; net loss $4.2M.
Operating loss widened to $6.2M from $4.7M; negative gross margin due to product mix.
Domestic sales 82.9% of total (down from 89.6%); international sales up 42.4% on EasyPoint needle sales.
In April 2026, workforce reduced by ~16%, expected to save $2.2M annually with ~$122K separation costs.
Tariff expenses fell to ~$12K in Q1 2026 due to domestic production increase (39% produced domestically).

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.